Market Place
Sourcing Support
Genmab A/S Share Capital Reduction
17 Apr 2026 //
GLOBENEWSWIRE
Major Shareholder Announcement
14 Apr 2026 //
GLOBENEWSWIRE
Major Shareholder Announcement
01 Apr 2026 //
GLOBENEWSWIRE
Major Shareholder Announcement
30 Mar 2026 //
GLOBENEWSWIRE
Genmab Forms Board, Grants RSUs and Warrants to Staff
19 Mar 2026 //
GLOBENEWSWIRE
Genmab A/S Annual General Meeting Concludes
19 Mar 2026 //
GLOBENEWSWIRE
Completion of Share Buyback Program
16 Mar 2026 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
09 Mar 2026 //
GLOBENEWSWIRE
Genmab A/S Managers And Associates Engage In Share Transactions
02 Mar 2026 //
GLOBENEWSWIRE
Share Buy-Back Program Transactions
02 Mar 2026 //
GLOBENEWSWIRE
Correction To Company Announcement No. 13 Of March 2, 2026
02 Mar 2026 //
GLOBENEWSWIRE
Genmab Grants Restricted Stock Units And Warrants To Management
27 Feb 2026 //
GLOBENEWSWIRE
Genmab A/S Managers And Associates Engage In Share Transactions
27 Feb 2026 //
GLOBENEWSWIRE
Genmab To Participate In Upcoming Investor Conferences
25 Feb 2026 //
GLOBENEWSWIRE
Genmab Sees Capital Boost From Employee Warrant Exercise
24 Feb 2026 //
GLOBENEWSWIRE
Share Buyback Program Transactions
23 Feb 2026 //
GLOBENEWSWIRE
Notice to Convene the Annual General Meeting of Genmab A/S
18 Feb 2026 //
GLOBENEWSWIRE
Genmab Files Annual Report with US SEC
17 Feb 2026 //
GLOBENEWSWIRE
Genmab Announces Initiation Of Share Buy-Back Program
17 Feb 2026 //
GLOBENEWSWIRE
Genmab Publishes 2025 Annual Report
17 Feb 2026 //
GLOBENEWSWIRE
Genmab Grants Restricted Stock Units And Warrants To Employees
29 Jan 2026 //
GLOBENEWSWIRE
Genmab To Present At J.P. Morgan Healthcare Conference
05 Jan 2026 //
GLOBENEWSWIRE
Genmab Completes Tender Offer For Merus N.V. Shares
12 Dec 2025 //
PHARMIWEB
Genmab To Hold 2025 R&D Update And ASH Data Review Meeting
11 Dec 2025 //
GLOBENEWSWIRE
Genmab Closes Private Placement of Senior Unsecured Notes
03 Dec 2025 //
GLOBENEWSWIRE
Genmab A/S Managers And Associates Engage In Share Transactions
01 Dec 2025 //
GLOBENEWSWIRE
Genmab to Participate in Chat at Citi Global Healthcare Conf
24 Nov 2025 //
GLOBENEWSWIRE
Genmab Discloses Details On Proposed Private Offering Of Notes
10 Nov 2025 //
GLOBENEWSWIRE
Genmab Announces Private Placement of Secured/Unsecured Notes
10 Nov 2025 //
GLOBENEWSWIRE
Genmab Announces Financial Results For The Nine Months Of 2025
06 Nov 2025 //
GLOBENEWSWIRE
Genmab Joins Fireside Chat at Jefferies Global Healthcare Conf
05 Nov 2025 //
GLOBENEWSWIRE
Genmab Initiates Tender Offer For Merus N.V. Shares
21 Oct 2025 //
GLOBENEWSWIRE
Genmab Acquires Merus, Boosts Late-Stage Pipeline
30 Sep 2025 //
BUSINESSWIRE
Genmab Grants Restricted Stock Units And Warrants To Employees
25 Sep 2025 //
GLOBENEWSWIRE
Genmab A/s Managerial Employees and Associates` Share Transaction
17 Jun 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
02 Jun 2025 //
GLOBENEWSWIRE
Genmab to Join Fireside Chat at 2025 Jefferies Conference
21 May 2025 //
GLOBENEWSWIRE
Genmab`s Capital Increases Due to Employee Warrant Exercise
20 May 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
19 May 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
12 May 2025 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
22 Apr 2025 //
GLOBENEWSWIRE
Genmab A/S Share Capital Reduction
10 Apr 2025 //
GLOBENEWSWIRE
Genmab To Defend Against Trade Secret Claims By AbbVie
21 Mar 2025 //
GLOBENEWSWIRE
Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
26 Aug 2024 //
GLOBENEWSWIRE
Genmab shuffles C-Suite on commercialization, manufacturing as portfolio grows
19 Aug 2024 //
FIERCE PHARMA
Genmab Announces Changes to its Executive Committee
16 Aug 2024 //
GLOBENEWSWIRE
Capital Increase in Genmab as a Result of Employee Warrant Exercise
13 Aug 2024 //
GLOBENEWSWIRE
Genmab A/S Reports Insider Transactions
13 Aug 2024 //
GLOBENEWSWIRE
Genmab Updates 2024 Financial Guidance
08 Aug 2024 //
GLOBENEWSWIRE
Genmab Announces Financial Results for the First Half of 2024
08 Aug 2024 //
GLOBENEWSWIRE
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2024
17 Jul 2024 //
GLOBENEWSWIRE
Completion of Share Buy-back Program
27 Jun 2024 //
GLOBENEWSWIRE
EPKINLY Approved By FDA For Relapsed Follicular Lymphoma
26 Jun 2024 //
BUSINESSWIRE
Transactions in Connection with Share Buy-back Program
24 Jun 2024 //
GLOBENEWSWIRE
Capital Increase in Genmab as a Result of Employee Warrant Exercise
18 Jun 2024 //
GLOBENEWSWIRE
Transactions In Connection With Share Buy-back Program
17 Jun 2024 //
GLOBENEWSWIRE
Grant of Restricted Stock Units and Warrants to Employees in Genmab
12 Jun 2024 //
GLOBENEWSWIRE
Transactions with shares & linked securities in Genmab made by managerial
11 Jun 2024 //
GLOBENEWSWIRE
Transactions in Connection with Share Buy-back Program
10 Jun 2024 //
GLOBENEWSWIRE
Genmab: Fireside Chat At Goldman Sachs Healthcare Conference
05 Jun 2024 //
GLOBENEWSWIRE
